Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.38 |
| ▸ | PGK2 | P07205 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | PGD | P52209 | 1/20 | 0.35 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19281218 | 1.00 | PGK1 (0.38) | PGK1PGK2LAP3TP53PGD | |
| SCHEMBL1840428 | 1.00 | PGK1 (0.38) | PGK1PGK2LAP3TP53PGD | |
| SCHEMBL27241907 | 0.97 | PGK1 (0.37) | PGK1PGK2LAP3TP53PGD | |
| SCHEMBL26913628 | 0.97 | PGK1 (0.37) | PGK1PGK2LAP3TP53PGD | |
| SCHEMBL23931184 | 0.95 | PGK1 (0.35) | PGK1PGK2LAP3TP53PGD | |
| SCHEMBL183389 | 0.79 | SMPD1 (0.34) | PGK1PGK2SMPD1TDP1 | |
| SCHEMBL8416620 | 0.78 | PEPD (0.43) | PGK1PGK2LAP3SMPD1KDM4E | |
| SCHEMBL11522192 | 0.77 | CA4 (0.40) | LAP3PGDSMPD1TDP1 | |
| Ammonia Solution, Strong SCHEMBL28328876 | 0.77 | SMPD1 (0.33) | PGK1PGK2SMPD1TDP1 | |
| SCHEMBL12257190 | 0.77 | LAP3 (0.44) | LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107075588-B | Methods and systems for microbiome-derived diagnosis and treatment | 普梭梅根公司 | 2023-03-21 | — | — | CN | claimed |
| EP-2872514-B1 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-08-30 | — | — | EP | claimed |
| CN-107075588-B | Methods and systems for microbiome-derived diagnosis and treatment | 普梭梅根公司 | 2023-03-21 | — | — | CN | disclosed |
| US-20150353961-A1 | Designer Photoautotrophic and Hydrogenotrophic Production of Alcohols and Biodiesel | LEE JAMES WEIFU (US) | 2015-12-10 | — | — | US | disclosed |
| US-20130344553-A1 | Designer Calvin-Cycle-Channeled and Hydrogenotrophic Production of Butanol and Related Higher Alcohols | LEE JAMES WEIFU (US) | 2013-12-26 | — | — | US | disclosed |
| EP-2655599-A2 | DESIGNER CALVIN-CYCLE-CHANNELED AND HYDROGENOTROPHIC PRODUCTION OF BUTANOL AND RELATED HIGHER ALCOHOLS | Lee, James Weifu (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012088071-A2 | DESIGNER CALVIN-CYCLE-CHANNELED AND HYDROGENOTROPHIC PRODUCTION OF BUTANOL AND RELATED HIGHER ALCOHOLS | LEE JAMES WEIFU (US) | 2012-06-28 | — | — | WO | disclosed |